OWENS DAVID (Chief Medical Officer) purchased 0.6% of their position (1K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $3.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/5/2025ACC: 0001829126-25-000724
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+1K
Net shares
Net buyer
$3.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+1K
Price / share
$3.10
Trade value
$3.10K
% of position
0.6%
2/4/2025
154.79K→155.79K
Total
Net shares
+1K
Net value
$3.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 2/4/2025 | P · Purchase | +1K | $3.10 | $3.10K | 0.6% | 154.79K | 155.79K |
| Total | +1K | $3.10K | ||||||
Derivative Transactions0
No derivative transactions reported